Literature DB >> 25733443

Heart valve disease in general practice: a clinical overview.

Jessica Webb1, Chris Arden2, John B Chambers1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25733443      PMCID： PMC4337310          DOI： 10.3399/bjgp15X684217

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  9 in total

Review 1.  The medical management of valvar heart disease.

Authors:  N A Boon; P Bloomfield
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.

Authors:  Anji T Yetman; Renee A Bornemeier; Brian W McCrindle
Journal:  Am J Cardiol       Date:  2005-05-01       Impact factor: 2.778

Review 3.  Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.

Authors:  Antonio Pelliccia; Robert Fagard; Hans Halvor Bjørnstad; Aris Anastassakis; Eloisa Arbustini; Deodato Assanelli; Alessandro Biffi; Mats Borjesson; François Carrè; Domenico Corrado; Pietro Delise; Uwe Dorwarth; Asle Hirth; Hein Heidbuchel; Ellen Hoffmann; Klaus P Mellwig; Nicole Panhuyzen-Goedkoop; Angela Pisani; Erik E Solberg; Frank van-Buuren; Luc Vanhees; Carina Blomstrom-Lundqvist; Asterios Deligiannis; Dorian Dugmore; Michael Glikson; Per Ivar Hoff; Andreas Hoffmann; Erik Hoffmann; Dieter Horstkotte; Jan Erik Nordrehaug; Jan Oudhof; William J McKenna; Maria Penco; Silvia Priori; Tony Reybrouck; Jeff Senden; Antonio Spataro; Gaetano Thiene
Journal:  Eur Heart J       Date:  2005-05-27       Impact factor: 29.983

4.  Can we improve the detection of heart valve disease?

Authors:  Chris Arden; John B Chambers; Jonathan Sandoe; Simon Ray; Bernard Prendergast; David Taggart; Stephen Westaby; Lucy Grothier; Jo Wilson; Brian Campbell; Christa Gohlke-Bärwolf; Carlos A Mestres; Raphael Rosenhek; Philippe Pibarot; Catherine M Otto
Journal:  Heart       Date:  2013-05-30       Impact factor: 5.994

5.  Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease.

Authors:  John B Chambers; Simon Ray; Bernard Prendergast; David Taggart; Stephen Westaby; Lucy Grothier; Chris Arden; Jo Wilson; Brian Campbell; Jonathan Sandoe; Christa Gohlke-Bärwolf; Carlos-A Mestres; Raphael Rosenhek; Catherine Otto
Journal:  Heart       Date:  2013-03-26       Impact factor: 5.994

6.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

7.  Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.

Authors:  J Shores; K R Berger; E A Murphy; R E Pyeritz
Journal:  N Engl J Med       Date:  1994-05-12       Impact factor: 91.245

8.  Burden of valvular heart diseases: a population-based study.

Authors:  Vuyisile T Nkomo; Julius M Gardin; Thomas N Skelton; John S Gottdiener; Christopher G Scott; Maurice Enriquez-Sarano
Journal:  Lancet       Date:  2006-09-16       Impact factor: 79.321

9.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.